{
    "clinical_study": {
        "@rank": "67131", 
        "arm_group": {
            "arm_group_label": "Low-Risk BCC Excisional Margins", 
            "arm_group_type": "Other", 
            "description": "This is a study investigating the efficiency of 1-2 mm margins for the excision of low-risk basal cell carcinoma."
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine if narrow (1 and 2mm) margins are successful\n      excision margins for National Comprehensive Cancer Network (NCCN) low-risk facial Basal Cell\n      Carcinoma."
        }, 
        "brief_title": "Long Term Prospective Study Evaluating Effectiveness of Narrow Margins for Low-Risk Facial Basal Cell Carinomas", 
        "completion_date": {
            "#text": "November 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Basal Cell Carcinoma", 
        "condition_browse": {
            "mesh_term": [
                "Carcinoma", 
                "Carcinoma, Basal Cell"
            ]
        }, 
        "detailed_description": {
            "textblock": "Current recommendations for excision (removal) of Basal Cell Carcinoma (BCC), a type of skin\n      cancer, vary by tumor (grouping of cancer cells) size, location on the body, appearance\n      under the microscope, and surgeon preference. Recent articles have included more aggressive\n      and larger size tumors, in addition to small low-risk tumors, within their study population.\n      The purpose of this study is to determine the successful excision margins (area of skin\n      around the tumor) for National Comprehensive Cancer Network (NCCN) low-risk facial BCC."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patient has a BCC <10mm on their cheeks, forehead, scalp & neck or <6mm on their\n             central face, eyelids, eyebrows, periorbital, nose, lips, chin, mandible,\n             preauricular & postauricular, temple & ear\n\n          -  The BCC has well defined borders\n\n          -  The BCC is primary\n\n          -  The Patient is not immunosuppressed\n\n          -  The BCC is not located at a site of prior radiation therapy\n\n          -  The histologic subtype is nodular or superficial\n\n          -  There is no perineural involvement\n\n        Exclusion Criteria:\n\n          -  Patient has a BCC >or=10mm on their cheeks, forehead, scalp & neck or >or=6mm on\n             their central face, eyelids, eyebrows, periorbital, nose, lips, chin, mandible,\n             preauricular & postauricular, temple & ear\n\n          -  The BCC has poorly defined borders\n\n          -  The BCC is recurrent\n\n          -  The Patient is immunosuppressed\n\n          -  The BCC is located at a site of prior radiation therapy\n\n          -  The histologic subtype is aggressive\n\n          -  There is perineural involvement"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "179", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 15, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01903239", 
            "org_study_id": "IRB#11D.479"
        }, 
        "intervention": {
            "arm_group_label": "Low-Risk BCC Excisional Margins", 
            "description": "This study is purely about the technique of excision used to remove low-risk basal cell carcinomas. 1 - 2 mm surgical margins are being used to excise low risk facial basal cell carcinomas. The tools used for the excision and the surgical procure itself have not changed from the standard of care. The only change is the size of the margin being taken. Patients that typically would see a Mohs Surgeon to get the smallest possible margins and scars will no longer need to see a specialist. Dermatologist will be able to extract the low risk cancers with confidence that the complete lesion has been removed and minimal scar has been left.", 
            "intervention_name": "Low-Risk BCC Excisional Margins", 
            "intervention_type": "Procedure"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "February 4, 2014", 
        "location": [
            {
                "contact": {
                    "last_name": "Laura", 
                    "phone": "215-639-7546"
                }, 
                "facility": {
                    "address": {
                        "city": "Bensalem", 
                        "country": "United States", 
                        "state": "Pennsylvania", 
                        "zip": "19020"
                    }, 
                    "name": "Advanced Aesthetics"
                }, 
                "investigator": [
                    {
                        "last_name": "Wayne Marley, MD", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Daria Marley Kemp, MEd, BS", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "kfs001@jefferson.edu", 
                    "last_name": "Katherine Sohon, BS", 
                    "phone": "215-955-1058"
                }, 
                "facility": {
                    "address": {
                        "city": "Philadelphia", 
                        "country": "United States", 
                        "state": "Pennsylvania", 
                        "zip": "19107"
                    }, 
                    "name": "Jefferson Dermatology Associates"
                }, 
                "investigator": [
                    {
                        "last_name": "Joya Sahu, MD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Jason B Lee, MD", 
                        "role": "Principal Investigator"
                    }
                ], 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "Long Term Prospective Study Evaluating Effectiveness of Narrow Margins for Low-Risk Facial Basl Cell Carcinomas", 
        "overall_contact": {
            "email": "kfs001@jefferson.edu", 
            "last_name": "Katherine Sohon, BS", 
            "phone": "215-955-1058"
        }, 
        "overall_official": {
            "affiliation": "Jefferson Dermatology Associates", 
            "last_name": "Jason B Lee, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "November 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Success rate of narrow (1 and 2mm)margin excision of low-risk facial BCC", 
            "safety_issue": "No", 
            "time_frame": "3 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01903239"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Thomas Jefferson University", 
        "sponsors": {
            "collaborator": {
                "agency": "Advanced Aesthetics", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Thomas Jefferson University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2011", 
        "study_design": "Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}